-
Online Discussions Reveal Little-Known Side Effects
Analyzing online patient conversations could shed light on adverse drug reactions.
by Brad Jones
-
Is 3-D Mammography Better?
A study enrolling patients compares a newer form of digital mammography to conventional 2-D digital mammography.
by Marci A. Landsmann
-
When Cancer Survivors Get Another Cancer
Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
by Kate Yandell
-
Chemotherapy Essentials
Stock your bag with these useful items before your next infusion session.
by Jamie L. Schwachter
-
Welcome to Our New Website
An updated site and a new digital editor means better and faster cancer coverage for our readers.
by Cancer Today Staff
Previous |
Cancer Talk
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon